Are there any specialized B12 formulations for dual deficiencies
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
Note: This is not medical advice
The authors described TB4 as acting through promotion of cell migration, stem cell mobilisation and differentiation, and inhibition of inflammation and apoptosis
In addition, migraine medication use was decreased in the B6, folic acid, B12, and B vitamin combination groups, but not in the B1 or placebo groups (Nematgorgani 2022)